Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Focal Epilepsy”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Post-approval studies (Phase 4)UnknownNCT02726919
What this trial is testing

Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy

Who this might be right for
Epilepsy
Pavel Klein 20
Not applicableStudy completedNCT03533530
What this trial is testing

Clinical Utility of ESI in Presurgical Evaluation of Patients With Epilepsy

Who this might be right for
ElectroencephalographyRefractory EpilepsyBrain Imaging+1 more
Rigshospitalet, Denmark 82
Not applicableLooking for participantsNCT03644732
What this trial is testing

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

Who this might be right for
Refractory EpilepsyFocal Epilepsy
University Hospital, Grenoble 200
Large-scale testing (Phase 3)Study completedNCT00957684
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Refractory Partial Epilepsy
Bial - Portela C S.A. 402
Not applicableStudy completedNCT00071305
What this trial is testing

Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 35
Testing effectiveness (Phase 2)Study completedNCT02170064
What this trial is testing

Pharmacokinetics, Efficacy and Tolerability of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 35
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Not applicableUnknownNCT04383028
What this trial is testing

MELD as an Adjunct for SEEG Trajectories

Who this might be right for
EpilepsyEpilepsy, FocalEpilepsy, Refractory
Great Ormond Street Hospital for Children NHS Foundation Trust 20
Not applicableActive Not RecruitingNCT06681480
What this trial is testing

Transcranial Magnetic Stimulation (rTMS) for Refractory Focal Epilepsy

Who this might be right for
Focal EpilepsyTranscranial Magnetis Stimulation
Comenius University 20
Testing effectiveness (Phase 2)Study completedNCT00141414
What this trial is testing

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Who this might be right for
Epilepsy, Partial
Pfizer 82
Testing effectiveness (Phase 2)Study completedNCT00236730
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 178
Not applicableNot Yet RecruitingNCT07399327
What this trial is testing

Biomarkers of Response to SEEG Thermocoagulation

Who this might be right for
Drug Resistant Epilepsy
Assistance Publique Hopitaux De Marseille 45
Testing effectiveness (Phase 2)Study completedNCT00236847
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60
Very early researchUnknownNCT05886205
What this trial is testing

Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

Who this might be right for
Refractory Focal Epilepsy
Peking Union Medical College Hospital 34
Not applicableUnknownNCT03321240
What this trial is testing

Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia

Who this might be right for
Refractory EpilepsyFocal EpilepsyFocal Cortical Dysplasia
University Hospital, Strasbourg, France 240
Early research (Phase 1)Study completedNCT01703143
What this trial is testing

Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy

Who this might be right for
Epilepsy
Mayo Clinic 14
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Not applicableStudy completedNCT00001666
What this trial is testing

Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy

Who this might be right for
Partial EpilepsySeizures
National Institute of Neurological Disorders and Stroke (NINDS) 32
Not applicableStudy completedNCT03278210
What this trial is testing

National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug

Who this might be right for
Epilepsy IntractableFocal Epilepsy
University Hospital, Lille 102
Not applicableStudy completedNCT04770337
What this trial is testing

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory EpilepsyFocal SeizureSeizures, Focal+4 more
Neuroelectrics Corporation 127
Load More Results